Pliant Therapeutics (PLRX) PT Raised to $40 at Piper Sandler
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.07 -0.93%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Tyler Van Buren raised the price target on Pliant Therapeutics (NASDAQ: PLRX) to $40.00 (from $27.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
